Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1‐inhibitor concentrate

Publisher: John Wiley & Sons Inc

E-ISSN: 1398-9995|70|10|1319-1328

ISSN: 0105-4538

Source: ALLERGY, Vol.70, Iss.10, 2015-10, pp. : 1319-1328

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract